UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Informing the delivery of cancer survivorship care in rural primary care practice

Journal of cancer survivorship, 2022-02, Vol.16 (1), p.4-12

2022

Volltextzugriff (PDF)

Malignant Transformation of Adult Low Grade Glioma: Risk Factors and Outcomes in the Molecular Era

International journal of radiation oncology, biology, physics, 2019-09, Vol.105 (1), p.S143-S143

2019

Volltextzugriff (PDF)

Treatment Outcome of Adult Primary Spinal Cord Lymphoma: A Population-Based Study

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.E500-E501

2016

Volltextzugriff (PDF)

Results of phase II trial of SL-701, a novel immunotherapy targeting IL-13Ra2, EphA2, and survivin, in adults with second-line recurrent glioblastoma (GBM)

Annals of oncology, 2018-10, Vol.29, p.viii122-viii123

2018

Volltextzugriff (PDF)

Pulsed Reduced Dose Rate Reirradiation for Recurrent Primary Central Nervous System Tumors

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E112-E112

2015

Volltextzugriff (PDF)

Prognostic Factors for Adult Low Grade Glioma Patients 40 Years of Age and Younger

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E114-E114

2015

Volltextzugriff (PDF)

Changing Trends in Brain Metastasis: A 20-Year Review of Patient Outcomes

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.E518-E518

2016

Volltextzugriff (PDF)

Institutional Experience of High-Risk, Low-Grade Glioma in the Temozolomide Era

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.E115-E115

2016

Volltextzugriff (PDF)

Aggressive treatment is appropriate for glioblastoma multiforme patients 70 years old or older: a retrospective review of 206 cases

Neuro-oncology (Charlottesville, Va.), 2011-04, Vol.13 (4), p.428-436

2011

Volltextzugriff (PDF)

Intracranial hemorrhage in setting of glioblastoma with venous thromboembolism

Journal of the neurological sciences, 2015-10, Vol.357, p.e76-e77

2015

Volltextzugriff (PDF)

P1566: PROTON PUMP INHIBITION FOR SECONDARY HEMOCHROMATOSIS IN HEREDITARY ANEMIA, A PHASE III PLACEBO‐CONTROLLED RANDOMIZED CROSS‐OVER CLINICAL TRIAL

HemaSphere, 2022-06, Vol.6 (Suppl), p.1447-1448

2022

Volltextzugriff (PDF)

Cilengitide Inhibits Proliferation and Shows Combined Effects With Radiation in Breast Cancer Cell Lines

International journal of radiation oncology, biology, physics, 2013-10, Vol.87 (2), p.S658-S658

2013

Volltextzugriff (PDF)

A Cure Is Possible: A Study of 10 Year Survivors of Brain Metastases

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E98-E98

2015

Volltextzugriff (PDF)

Determining the Optimal Management of Patients With Limited-Brain Metastases: A Cost Analysis Approach

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E354-E354

2015

Volltextzugriff (PDF)

Adult Medulloblastoma: Does Craniospinal Dose Matter?

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S321-S322

2014

Volltextzugriff (PDF)

P17.83 OUTCOMES OF RECURRENT GLIOBLASTOMA PATIENTS TREATED WITH BEVACIZUMAB AT A TERTIARY CARE CENTER

Neuro-oncology (Charlottesville, Va.), 2014-09, Vol.16 (suppl 2), p.ii107-ii107

2014

Volltextzugriff (PDF)

Impact of 1p Status and Radiation Therapy Timing on Long-term Outcomes for Adults With Grade 2 Glioma Treated at a Single Institution

International journal of radiation oncology, biology, physics, 2013-10, Vol.87 (2), p.S258-S259

2013

Volltextzugriff (PDF)

P07.09.B A RANDOMIZED PHASE 2B STUDY OF SURVIVIN VACCINE SURVAXM PLUS ADJUVANT TEMOZOLOMIDE FOR NEWLY-DIAGNOSED GLIOBLASTOMA (SURVIVE)

Neuro-oncology (Charlottesville, Va.), 2023-09, Vol.25 (Suppl 2), p.ii52-ii53

2023

Volltextzugriff (PDF)

Three Decade Single-Institution Experience of Safety and Efficacy of Radiotherapy and Adjuvant Chemotherapy for Young Adult Patients with Medulloblastoma

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.e511-e512

2023

Volltextzugriff (PDF)

Patterns Of Care And Outcomes Analysis For Adult Patients With Newly Diagnosed Medulloblastoma: A 30-Year Single Institution Experience

International journal of radiation oncology, biology, physics, 2020-11, Vol.108 (3), p.e745-e746

2020

Volltextzugriff (PDF)

Intraocular rituximab

Eye (London), 2007-12, Vol.21 (12), p.1453-1454

2007

Volltextzugriff (PDF)

JS06.5.A TUCATINIB, TRASTUZUMAB, AND CAPECITABINE WITH STEREOTACTIC RADIOSURGERY IN PATIENTS WITH BRAIN METASTASES FROM HER-2 POSITIVE BREAST CANCER (TUTOR): A MULTICENTER PHASE 1 CLINICAL TRIAL

Neuro-oncology (Charlottesville, Va.), 2023-09, Vol.25 (Supplement_2), p.ii10-ii11

2023

Volltextzugriff (PDF)

Phase II trial of neoadjuvant estramustine and etoposide plus radical prostatectomy for locally advanced prostate cancer

Urology (Ridgewood, N.J.), 2001-02, Vol.57 (2), p.281-285

2001

Volltextzugriff (PDF)

Sequences of topotecan and cisplatin: phase I, pharmacologic, and in vitro studies to examine sequence dependence

Journal of clinical oncology, 1996-12, Vol.14 (12), p.3074-3084

1996

Volltextzugriff (PDF)

Unsanctifying the sanctuary: challenges and opportunities with brain metastases

Neuro-oncology (Charlottesville, Va.), 2015-05, Vol.17 (5), p.639-651

2015

Volltextzugriff (PDF)

1 – 25 von 264

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(231)
Mit Volltextzugriff
(215)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(99)
Science & Technology
(97)
Life Sciences & Biomedicine
(94)
Female
(58)
Adult
(56)
Oncology
(52)
Biological And Medical Sciences
(50)
Male
(49)
Medical Sciences
(48)
Middle Aged
(47)
Aged
(36)
Pharmacology. Drug Treatments
(23)
Chemotherapy
(22)
Treatment Outcome
(20)
Antineoplastic Agents
(19)
Brain Neoplasms - Drug Therapy
(17)
Clinical Neurology
(16)
Neurosciences & Neurology
(16)
Dermatology
(15)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(14)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Informing the delivery of cancer survivorship care in rural primary care practice

Malignant Transformation of Adult Low Grade Glioma: Risk Factors and Outcomes in the Molecular Era

Treatment Outcome of Adult Primary Spinal Cord Lymphoma: A Population-Based Study

Results of phase II trial of SL-701, a novel immunotherapy targeting IL-13Ra2, EphA2, and survivin, in adults with second-line recurrent glioblastoma (GBM)

Pulsed Reduced Dose Rate Reirradiation for Recurrent Primary Central Nervous System Tumors

Prognostic Factors for Adult Low Grade Glioma Patients 40 Years of Age and Younger

Changing Trends in Brain Metastasis: A 20-Year Review of Patient Outcomes

Institutional Experience of High-Risk, Low-Grade Glioma in the Temozolomide Era

Aggressive treatment is appropriate for glioblastoma multiforme patients 70 years old or older: a retrospective review of 206 cases

Intracranial hemorrhage in setting of glioblastoma with venous thromboembolism

P1566: PROTON PUMP INHIBITION FOR SECONDARY HEMOCHROMATOSIS IN HEREDITARY ANEMIA, A PHASE III PLACEBO‐CONTROLLED RANDOMIZED CROSS‐OVER CLINICAL TRIAL

Cilengitide Inhibits Proliferation and Shows Combined Effects With Radiation in Breast Cancer Cell Lines

A Cure Is Possible: A Study of 10 Year Survivors of Brain Metastases

Determining the Optimal Management of Patients With Limited-Brain Metastases: A Cost Analysis Approach

Adult Medulloblastoma: Does Craniospinal Dose Matter?

P17.83 OUTCOMES OF RECURRENT GLIOBLASTOMA PATIENTS TREATED WITH BEVACIZUMAB AT A TERTIARY CARE CENTER

Impact of 1p Status and Radiation Therapy Timing on Long-term Outcomes for Adults With Grade 2 Glioma Treated at a Single Institution

P07.09.B A RANDOMIZED PHASE 2B STUDY OF SURVIVIN VACCINE SURVAXM PLUS ADJUVANT TEMOZOLOMIDE FOR NEWLY-DIAGNOSED GLIOBLASTOMA (SURVIVE)

Three Decade Single-Institution Experience of Safety and Efficacy of Radiotherapy and Adjuvant Chemotherapy for Young Adult Patients with Medulloblastoma

Patterns Of Care And Outcomes Analysis For Adult Patients With Newly Diagnosed Medulloblastoma: A 30-Year Single Institution Experience

Intraocular rituximab

JS06.5.A TUCATINIB, TRASTUZUMAB, AND CAPECITABINE WITH STEREOTACTIC RADIOSURGERY IN PATIENTS WITH BRAIN METASTASES FROM HER-2 POSITIVE BREAST CANCER (TUTOR): A MULTICENTER PHASE 1 CLINICAL TRIAL

Phase II trial of neoadjuvant estramustine and etoposide plus radical prostatectomy for locally advanced prostate cancer

Sequences of topotecan and cisplatin: phase I, pharmacologic, and in vitro studies to examine sequence dependence

Unsanctifying the sanctuary: challenges and opportunities with brain metastases

Suchergebnisse filtern